Clinical Trial Update: A Study of NINLARO® in Chinese Adults With Multiple Myeloma

View source ↗

Summary

This clinical trial update reports the status of a study evaluating NINLARO (ixazomib) in Chinese adults with multiple myeloma; the trial is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• NINLARO (ixazomib)

Snippet

Sponsor: Takeda | Conditions: Multiple Myeloma | Status: ACTIVE_NOT_RECRUITING